Cocrystal Pharma, Inc. (COCP) Misses Q3 EPS by 49c

Cocrystal Pharma, Inc. (NASDAQ: COCP) reported Q3 EPS of ($0.49).

For earnings history and earnings-related data on Cocrystal Pharma, Inc. (COCP) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Caro Holdings Announces Asset Purchase and Framework for Acquisition of Goldrange Resources Corp
• Invesco Mortgage Capital declares $0.12 monthly dividend for June 2026